ClassID:

20642

A61K35/545 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs; Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells

Recent Application in this class:
#1
20260125646
2026-05-07

IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE-SPECIFIC POPULATIONS

#2
20260124248
2026-05-07

TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT IN SEXUAL QUALITY OF LIFE

#3
20260097085
2026-04-09

AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

#4
20260083780
2026-03-26

COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF

#5
20260062680
2026-03-05

METHOD FOR PRODUCING CELL AGGREGATES

#6
20260061009
2026-03-05

METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION

#7
20260041718
2026-02-12

COMPOSITIONS, DEVICES, AND METHODS RELATING TO USE OF AN AMNIOTIC MEMBRANE FETAL TISSUE PRODUCT

#8
20260035664
2026-02-05

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION

#9
20260022346
2026-01-22

HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME

#10
20260021145
2026-01-22

SUPERNATANT OF BROWN ADIPOCYTES, METHOD FOR PREPARING SAME AND UTILIZATION THEREOF

#11
20260008998
2026-01-08

METHODS OF MAKING AND USING IMMUNE-TOLERIZED FETAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR HAIR LOSS TREATMENT

#12
20250382582
2025-12-18

SYSTEMS FOR STEM CELL PROGRAMMING AND METHODS THEREOF

#13
20250375484
2025-12-11

Vascular associated naturally pluripotent stem cell and method of isolation

#14
20250361482
2025-11-27

APOPTOSIS-INDUCED STEM CELLS, PRODUCTION METHOD THEREFOR, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY OR RENAL DISEASES

#15
20250360172
2025-11-27

MICROGEL-ENCAPSULATED IPSC-DERIVED NOTOCHORDAL CELLS FOR TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND DISCOGENIC PAIN

#16
20250340612
2025-11-06

GENETICALLY MODIFIED CELLS AND USES THEREOF

#17
20250339471
2025-11-06

PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION

#18
20250332288
2025-10-30

CARDIOPROTECTIVE HEART DISEASE THERAPIES

#19
20250320461
2025-10-16

GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER

#20
20250319134
2025-10-16

TREATMENT OF IMMUNE DISORDERS

#21
20250295704
2025-09-25

OSTEOARTHRITIS TREATMENT COMPOSITION USING iPSC-DERIVED MITOCHONDRIA

#22
20250295703
2025-09-25

TREATMENT AGENT FOR HAIR DAMAGE

#23
20250270504
2025-08-28

METHODS FOR MANUFACTURING AND USING IMMUNE-TOLERIZED FETAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR OSTEOARTHRITIS TREATMENT

#24
20250270281
2025-08-28

ALLOGENEIC CAR-T PLATFORM USING HLA-MATCHED BANK OF IPSCS, AND RELATED COMPOSITIONS, SYSTEMS, AND METHODS

#25
20250269086
2025-08-28

Cell Population for Transplantation and Method for Producing Same

#26
20250268949
2025-08-28

IMMUNE CELL INHIBITION BY IMMUNE CHECKPOINT ENGAGERS

#27
20250268837
2025-08-28

COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE

#28
20250255807
2025-08-14

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTICS TO THE HEART

#29
20250242170
2025-07-31

Methods and Systems for Improving Photodynamic Therapy by Increasing Depth of Penetration Without Concurrently Increasing Energy Deposition

#30
20250222039
2025-07-10

UNIVERSAL CELL AND METHOD FOR PREPARING SAME

#31
20250215427
2025-07-03

Materials and Methods for Treatment of Hemoglobinopathies

#32
20250213470
2025-07-03

COMPOSITIONS AND METHODS

#33
20250205390
2025-06-26

BIOARTIFICIAL VASCULAR PANCREAS

#34
20250195584
2025-06-19

PHARMACEUTICAL AND COSMETIC AND METHOD FOR PROVIDING SAME

#35
20250186508
2025-06-12

PAR2 MODULATION TO ALTER MYELINATION

#36
20250145966
2025-05-08

ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF

#37
20250144154
2025-05-08

ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION

#38
20250134932
2025-05-01

PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF

#39
20250127821
2025-04-24

PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION

#40
20250115931
2025-04-10

ENHANCED GENE DELIVERY METHODS

#41
20250101460
2025-03-27

Controllable Transcription

#42
20250073278
2025-03-06

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

#43
20250059286
2025-02-20

ARTIFICIAL CELL DEATH POLYPEPTIDE FOR CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

#44
20250019650
2025-01-16

NEURAL CELL EXTRACELLULAR VESICLES

#45
20250002905
2025-01-02

MODIFIED CELLS AND METHODS OF USE THEREOF

#46
20250000788
2025-01-02

BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS

#47
20240415894
2024-12-19

MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA

#48
20240400987
2024-12-05

METHODS OF IN VITRO DIFFERENTIATION OF MIDBRAIN DOPAMINE (MDA) NEURONS

#49
20240398874
2024-12-05

COMPOSITION FOR TREATMENT OF WOUNDS CONTAINING STEM CELL-DERIVED EXOSOMES AND METHOD FOR PREPARING SAME

#50
20240392252
2024-11-28

GENERATING CARDIAC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS USING ISOXAZOLE OR ISOXAZOLE LIKE COMPOUNDS

#51
20240390460
2024-11-28

ANTIBODY RESISTANT MODIFIED RECEPTORS TO ENHANCE CELL-BASED THERAPIES

#52
20240382534
2024-11-21

MITOCHONDRIAL AUGMENTATION THERAPY FOR MYELODYSPLASTIC SYNDROME

#53
20240366737
2024-11-07

COMPOSITIONS FOR INHIBITING TERATOMA FORMATION AND GROWTH COMPRISING TIMP-1 AND TIMP-2 AS EFFECTIVE COMPONENTS

#54
20240366684
2024-11-07

COMPOSITIONS COMPRISING A ZIM3 EFFECTOR AND METHODS OF USE THEREOF

#55
20240360421
2024-10-31

MATERIALS AND METHODS FOR THE MANUFACTURE OF PLURIPOTENT STEM CELLS

#56
20240360238
2024-10-31

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

#57
20240358768
2024-10-31

Methods and Systems for Improved Therapies of Genetic Diseases Using Photo-Activated Allogenic Stem Cells

#58
20240352426
2024-10-24

Accelerated Protocol for the Differentiation of Podocytes from Human Pluripotent Stem Cells

#59
20240350548
2024-10-24

METHODS FOR GENERATION OF PODOCYTES FROM PLURIPOTENT STEM CELLS AND CELLS PRODUCED BY THE SAME

#60
20240335480
2024-10-10

VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)-HIGHLY EXPRESSING PERICYTE-LIKE CELL

#61
20240327799
2024-10-03

COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA

#62
20240316197
2024-09-26

HUMAN IPSC-DERIVED MACROPHAGE

#63
20240316117
2024-09-26

PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION

#64
20240299462
2024-09-12

ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A

#65
20240277776
2024-08-22

HYPOIMMUNE CELLS

#66
20240252687
2024-08-01

GENE THERAPY FOR WET AGE-RELATED MACULAR DEGENERATION USING IPSC-DERIVED CELLS AS VECTORS

#67
20240252551
2024-08-01

NOVEL PLURIPOTENT CELLS

#68
20240238239
2024-07-18

METHODS AND COMPOSITIONS FOR POTENTIATING STEM CELL THERAPIES

#69
20240226182
2024-07-11

EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION

#70
20240218325
2024-07-04

MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE

#71
20240200098
2024-06-20

Controllable Transcription

#72
20240191205
2024-06-13

EFFICIENT AND NON-GENETICALLY MODIFIED IPSC-INDUCED, INDUSTRIALIZED SINGLE CLONE SELECTION PLATFORM, AND USE

#73
20240181005
2024-06-06

COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS

#74
20240180972
2024-06-06

HUMAN PLURIPOTENT STEM CELL-DERIVED SECRETOME AS A BIOLOGIC FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE AND APOPTOTIC DISEASES

#75
20240174978
2024-05-30

MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

#76
20240173358
2024-05-30

Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion

#77
20240173355
2024-05-30

GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS

#78
20240158788
2024-05-16

METHODS AND COMPOSITIONS USED TO MODIFY CHROMATIN ARCHITECTURE TO REGULATE PHENOTYPE IN AGING AND CANCER

#79
20240131080
2024-04-25

METHOD FOR REPROGRAMMING HUMAN CELLS

#80
20240131079
2024-04-25

EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION

#81
20240091329
2024-03-21

METHOD OF INHIBITING LUNG OR BREAST CANCER GROWTH WITH ENGINEERED EMBRYONIC STEM-CELL DERIVED EXOSOMES COMPOSITIONS

#82
20240091274
2024-03-21

TRANSPLANTED CELL PROTECTION VIA Fc SEQUESTRATION

#83
20240076660
2024-03-07

GENE CORRECTION OF POMPE DISEASE AND OTHER AUTOSOMAL RECESSIVE DISORDERS VIA RNA-GUIDED NUCLEASES

#84
20240075075
2024-03-07

REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS

#85
20240041940
2024-02-08

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE

#86
20240041938
2024-02-08

PREVENTION OF SPACE TRAVEL ASSOCIATED BONE DENSITY LOSS BY REGENERATIVE CELL POPULATIONS

#87
20240034999
2024-02-01

IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PLURIPOTENT STEM CELLS

#88
20240033300
2024-02-01

METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGINEERED STABILIZATION OF EXPRESSION OF ENDOGENOUS FOXP3 GENE

#89
20240026386
2024-01-25

COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A

#90
20240024373
2024-01-25

Method to Improve Therapeutic Properties of Stem Cells

#91
20240016853
2024-01-18

MODIFIED IPSCS

#92
20240010992
2024-01-11

COMPOSITIONS AND METHODS TO IMPROVE IPSC-EC FUNCTION

#93
20240010980
2024-01-11

NATURAL KILLER CELLS WITH ENHANCED ACTIVITY

#94
20240002880
2024-01-04

Controllable Transcription

#95
20230414677
2023-12-28

Allograft tolerance without the need for systemic immune suppression

#96
20230405055
2023-12-21

DEVELOPMENT OF AMNION-LIKE TISSUE FROM HUMAN PLURIPOTENT STEM CELLS

#97
20230392165
2023-12-07

Controllable Transcription

#98
20230382999
2023-11-30

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

#99
20230381244
2023-11-30

Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells

#100
20230381240
2023-11-30

COMPOSITION FOR BONE REGENERATION CONTAINING HYDROGEL AND STEM CELL SPHEROID, AND USE THEREOF

#101
20230364228
2023-11-16

METHOD OF TREATING AMYLOIDOSIS

#102
20230364156
2023-11-16

TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS

#103
20230338434
2023-10-26

METHOD FOR TREATING ISCHEMIA CONDITION OF TISSUE

#104
20230338427
2023-10-26

MITOCHONDRIAL AUGMENTATION THERAPY

#105
20230332109
2023-10-19

ACTIVATED PLURIPOTENT STEM CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#106
20230330154
2023-10-19

METHODS OF TREATING SYSTEMIC GRAFT- VERSUS-HOST DISEASE WITH EXTRACELLULAR VESICLES

#107
20230330138
2023-10-19

TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF

#108
20230323309
2023-10-12

UNIVERSAL DONOR CELLS

#109
20230322897
2023-10-12

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#110
20230313227
2023-10-05

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA

#111
20230313131
2023-10-05

CELLS AND METHODS OF USES AND MAKING THE SAME

#112
20230293581
2023-09-21

METHODS OF TREATING SENSITIZED PATIENTS WITH HYPOIMMUNOGENIC CELLS, AND ASSOCIATED METHODS AND COMPOSITIONS

#113
20230287342
2023-09-14

Method for producing retinal pigment epithelial cells

#114
20230285470
2023-09-14

A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL

#115
20230279359
2023-09-07

WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS

#116
20230272429
2023-08-31

MODIFICATION OF BLOOD TYPE ANTIGENS

#117
20230270831
2023-08-31

METHODS FOR INDUCING SELECTIVE APOPTOSIS

#118
20230270788
2023-08-31

COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF

#119
20230265371
2023-08-24

DELIVERY DEVICES

#120
20230257774
2023-08-17

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#121
20230241123
2023-08-03

PLURIPOTENT STEM CELL AND DERIVATIVE THEREOF

#122
20230235296
2023-07-27

ENGINEERED MULTICELLULAR ORGANISMS

#123
20230227785
2023-07-20

METHODS FOR REPROGRAMMING CELLS AND USES THEREOF

#124
20230226148
2023-07-20

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

#125
20230226120
2023-07-20

Vascular associated naturally pluripotent stem cell and method of isolation

#126
20230212513
2023-07-06

COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION

#127
20230193210
2023-06-22

UNIVERSAL DONOR CELLS

#128
20230193209
2023-06-22

UNIVERSAL DONOR CELLS

#129
20230181651
2023-06-15

TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME

#130
20230175009
2023-06-08

IMMUNOLOGICALLY COMPATIBLE AND REVERSIBLE UNIVERSAL PLURIPOTENT STEM CELL AND APPLICATION THEREOF

#131
20230173110
2023-06-08

NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER

#132
20230172994
2023-06-08

METHODS OF PROMOTING VASCULOGENESIS

#133
20230165909
2023-06-01

GENE EDITING OF LRRK2 IN STEM CELLS AND METHOD OF USE OF CELLS DIFFERENTIATED THEREFROM

#134
20230165908
2023-06-01

CRYOPRESERVED ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A

#135
20230158111
2023-05-25

MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL STEM CELLS FOR CARTILAGE REGENERATION

#136
20230141347
2023-05-11

Treatment of immune disorders

#137
20230127586
2023-04-27

UNIVERSAL DONOR CELLS

#138
20230126434
2023-04-27

OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS

#139
20230123731
2023-04-20

MITOCHONDRIA-ENRICHED GENETICALLY ENGINEERED CELLS AND USES THEREOF

#140
20230117048
2023-04-20

STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE

#141
20230109431
2023-04-06

Methods of treating cancer using NK cells

#142
20230094922
2023-03-30

METHODS OF THERAPEUTIC PROGNOSTICATION

#143
20230090462
2023-03-23

ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF

#144
20230084480
2023-03-16

EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTS

#145
20230076688
2023-03-09

METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL LINE FROM MESENCHYMAL STEM CELLS, AND CELL LINE OBTAINED THEREBY

#146
20230069441
2023-03-02

Use of cell wall skeleton in regenerative medicine

#147
20230058557
2023-02-23

TRANSPLANTED CELL PROTECTION VIA INHIBITION OF POLYMORPHONUCLEAR CELLS

#148
20230058240
2023-02-23

METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM

#149
20230043161
2023-02-09

APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES

#150
20230025289
2023-01-26

CD24 EXPRESSING CELLS AND USES THEREOF

#151
20230000928
2023-01-05

PAR2 MODULATION TO ALTER MYELINATION

#152
20230000927
2023-01-05

METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS

#153
20220401493
2022-12-22

ISOLATION OF FUSION-COMPETENT MYOBLASTS AND THERAPEUTIC APPLICATIONS THEREOF RELATED TO MUSCULAR DYSTROPHY

#154
20220401487
2022-12-22

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES

#155
20220395536
2022-12-15

AGENT FOR TREATING OR PREVENTING VASCULAR DEMENTIA

#156
20220387516
2022-12-08

FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION

#157
20220387507
2022-12-08

THERAPY FOR INTERSTITIAL CYSTITIS BY PLURIPOTENT STEM CELLS

#158
20220380937
2022-12-01

IDENTIFICATION OF SPLICING-DERIVED ANTIGENS FOR TREATING CANCER

#159
20220378848
2022-12-01

COMPOSITIONS AND METHODS OF USING MULTIPOTENT STEM CELLS TO REDUCE DISEASE AND ENHANCE WELLNESS

#160
20220370582
2022-11-24

METHODS AND COMPOSITIONS FOR TREATING CANCERS

#161
20220370510
2022-11-24

AMELIORATION AND TREATMENT OF BRAIN DISORDER RESULTING FROM FETAL GROWTH RETARDATION USING PLURIPOTENT STEM CELLS

#162
20220370509
2022-11-24

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE

#163
20220356444
2022-11-10

Neural cell extracellular vesicles

#164
20220354902
2022-11-10

Methods of generating, repairing and/or maintaining connective tissue in vivo

#165
20220347348
2022-11-03

CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS

#166
20220347228
2022-11-03

PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS

#167
20220347222
2022-11-03

BCL11B Overexpression to Enhance Human Thymopoiesis and T Cell Function

#168
20220340877
2022-10-27

Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro

#169
20220339260
2022-10-27

METHOD FOR PRODUCING INSULIN-PRODUCING CELL USING DIHYDROINDOLIZINONE DERIVATIVES

#170
20220339102
2022-10-27

Composition for Preventing or Treating Salivary Gland Diseases Using Cell-Derived Vesicle

#171
20220331399
2022-10-20

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

#172
20220331371
2022-10-20

DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS

#173
20220323509
2022-10-13

THERAPEUTIC AGENT FOR MYOCARDITIS

#174
20220323508
2022-10-13

Compositions and methods for treating and preventing tissue injury and disease

#175
20220315902
2022-10-06

ENGINEERED ADULT-LIKE HUMAN HEART TISSUE

#176
20220313799
2022-10-06

COMPOSITIONS AND METHODS FOR EDITING A MUTATION TO PERMIT TRANSCRIPTION OR EXPRESSION

#177
20220305106
2022-09-29

GENETICALLY MODIFIED CELLS AND USES THEREOF

#178
20220298473
2022-09-22

LOW OXYGEN TENSION ENHANCES ENDOTHELIAL FATE OF HUMAN PLURIPOTENT STEM CELLS

#179
20220288121
2022-09-15

CELL CRYOPRESERVATION MEDIUM

#180
20220280569
2022-09-08

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

#181
20220267734
2022-08-25

HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF

#182
20220257666
2022-08-18

METHOD FOR SEPARATING PANCREATIC PROGENITOR CELLS

#183
20220257663
2022-08-18

PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS

#184
20220257656
2022-08-18

SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS

#185
20220241341
2022-08-04

METHODS TO REBALANCE THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS

#186
20220233606
2022-07-28

AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

#187
20220226379
2022-07-21

DNMT3A KNOCK-OUT STAT5 ACTIVATED GENETICALLY ENGINEERED T-CELLS

#188
20220226294
2022-07-21

Method of treating focal segmental glomerulosclerosis

#189
20220218760
2022-07-14

Universal donor cells

#190
20220213434
2022-07-07

MODIFIED PLURIPOTENT CELLS

#191
20220211770
2022-07-07

METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION

#192
20220211754
2022-07-07

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT

#193
20220204940
2022-06-30

Universal donor cells

#194
20220202948
2022-06-30

Agent for Eliminating Pluripotent Stem Cells

#195
20220184142
2022-06-16

CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS

#196
20220177592
2022-06-09

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

#197
20220169723
2022-06-02

Tagged chimeric effector molecules and receptors thereof

#198
20220168361
2022-06-02

METHODS FOR MEASURING THERAPEUTIC EFFECTS OF RETINAL DISEASE THERAPIES

#199
20220160789
2022-05-26

DUAL ANTIGEN-RECOGNIZING iPS CELL-DERIVED CHIMERIC ANTIGEN RECEPTOR-T-CELL THERAPY

#200
20220160788
2022-05-26

BIFUNCTIONAL VECTORS ALLOWING BCL11A SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF B-HEMOGLOBINOPATHIES

#201
20220154118
2022-05-19

Medical device having space for assisting in embedding of bio sample in embedding material

#202
20220152278
2022-05-19

IMPROVED SURVIVAL OF HUMAN CELLS DIFFERENTIATED IN VITRO BY PRPF31 GENE EXPRESSION KNOCKDOWN

#203
20220143102
2022-05-12

METHODS FOR ENHANCING LIFESPAN AND/OR TREATING CELLULAR PROLIFERATIVE DISORDERS BY TRANSPLANTATION

#204
20220133850
2022-05-05

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#205
20220133808
2022-05-05

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#206
20220125735
2022-04-28

MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION

#207
20220118028
2022-04-21

CELLS EXPRESSING PARATHYROID HORMONE 1 RECEPTOR AND USES THEREOF

#208
20220118026
2022-04-21

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#209
20220112472
2022-04-14

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

#210
20220112468
2022-04-14

NOVEL REPROGRAMMING METHOD

#211
20220111005
2022-04-14

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#212
20220110982
2022-04-14

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#213
20220088274
2022-03-24

Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue

#214
20220088087
2022-03-24

Pharmaceutical composition and cosmetic composition

#215
20220079998
2022-03-17

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY MACROPHAGE-MEDIATED AUTOIMMUNE DISEASE COMPRISING EXOSOMES DERIVED FROM STEM CELLS THAT ARE SURFACE-MODIFIED TO TARGET ACTIVATED MACROPHAGES

#216
20220064604
2022-03-03

SYSTEMIC SCLEROSIS DISEASE MODEL AND USE THEREOF

#217
20220041981
2022-02-10

MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE

#218
20220031819
2022-02-03

Compositions for inhibiting teratoma formation and growth comprising TIMP-1 and TIMP-2 as effective components

#219
20220025321
2022-01-27

Methods for reprograming non-pluripotent cells into pluripotent stem cells

#220
20220016181
2022-01-20

IMMUNOMODULATORY CELLS AND USES THEREOF

#221
20220008624
2022-01-13

Compositions and Structures for Regenerating Defective or Absent Myocardium

#222
20220008623
2022-01-13

Methods for Regenerating Defective or Absent Myocardium

#223
20220008535
2022-01-13

METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES

#224
20220008482
2022-01-13

Reprogramming Cells With Synthetic Messenger RNA

#225
20220000936
2022-01-06

THERAPEUTIC AGENT OF PERIPHERAL BLOOD FLOW DISORDER

#226
20210395697
2021-12-23

Materials and methods for the manufacture of pluripotent stem cells

#227
20210393701
2021-12-23

REGENERATIVE ABSCOPAL EFFECTS

#228
20210386791
2021-12-16

METHODS OF CELLULAR REPROGRAMMING

#229
20210371828
2021-12-02

INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION

#230
20210369781
2021-12-02

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

#231
20210340495
2021-11-04

METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF

#232
20210338736
2021-11-04

Methods for generation of podocytes from pluripotent stem cells and cells produced by the same

#233
20210322570
2021-10-21

Gene and cell therapy using cell fusion technology

#234
20210322485
2021-10-21

MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA

#235
20210317450
2021-10-14

MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES

#236
20210317228
2021-10-14

Anti-CD117 antibodies and conjugates

#237
20210308327
2021-10-07

Compositions and methods useful in regenerative medicine

#238
20210301258
2021-09-30

Method for Producing Dental Pulp-Derived Cells

#239
20210299185
2021-09-30

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#240
20210299173
2021-09-30

Enhancement of production of NK cells from stem cells

#241
20210290691
2021-09-23

Mitochondrial augmentation therapy of muscle diseases

#242
20210283187
2021-09-16

Compositions and methods for treating type 1 and type 2 diabetes and related disorders

#243
20210275599
2021-09-09

MITOCHONDRIAL AUGMENTATION THERAPY OF BRAIN DISEASES

#244
20210275598
2021-09-09

COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE

#245
20210275597
2021-09-09

Mitochondrial augmentation therapy of ocular diseases

#246
20210275587
2021-09-09

MITOCHONDRIAL AUGMENTATION THERAPY OF RENAL DISEASES

#247
20210261915
2021-08-26

Method of reinforcing efficacy of stem cells using ethionamide

#248
20210260137
2021-08-26

MITOCHONDRIAL AUGMENTATION THERAPY FOR PRIMARY MITOCHONDRIAL DISEASES

#249
20210252075
2021-08-19

MITOCHONDRIAL AUGMENTATION THERAPY OF LIVER DISEASES

#250
20210244773
2021-08-12

DENTAL PULP STEM CELLS AND USES THEREOF

#251
20210238584
2021-08-05

ISOLATION OF EXTRACELLULAR VESICLES BY PRECIPITATION OR IMMOBILIZATION USING POLYETHYLENIMINE AND POLYETHYLENIMINE-COATED SOLID SUPPORTS

#252
20210230549
2021-07-29

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION

#253
20210222126
2021-07-22

Methods and compositions for inducing hematopoietic cell differentiation

#254
20210220406
2021-07-22

Stem cell filtrate preparation and method for preparing same

#255
20210213068
2021-07-15

PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION

#256
20210206872
2021-07-08

Compositions and methods for the depletion of CD117+ cells

#257
20210198687
2021-07-01

Minimal volume reprogramming of mononuclear cells

#258
20210198371
2021-07-01

Anti-Ryk antibodies and methods of using the same

#259
20210196763
2021-07-01

Reprogramming Cells With Synthetic Messenger RNA

#260
20210187040
2021-06-24

IPSC-DERIVED SECRETOME COMPOSITIONS, AND RELATED SYSTEMS AND METHODS

#261
20210187031
2021-06-24

Transplant material for treatment of heart disease

#262
20210180026
2021-06-17

HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME

#263
20210180017
2021-06-17

Enhanced immune effector cells and use thereof

#264
20210177909
2021-06-17

SUPERNATANT OF BROWN ADIPOCYTES, METHOD FOR PREPARING SAME AND UTILIZATION THEREOF

#265
20210163895
2021-06-03

Enhanced immune effector cells and use thereof

#266
20210162031
2021-06-03

Methods and compositions for treating cancers

#267
20210161971
2021-06-03

ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION

#268
20210161967
2021-06-03

EXTRACELLULAR VESICLES AND USES THEREOF

#269
20210128785
2021-05-06

Bioartificial vascular pancreas

#270
20210128639
2021-05-06

CELL PREPARATION FOR TREATING BRAIN TUMOR

#271
20210123026
2021-04-29

Induced pluripotent stem cells (IPSCS) and applications thereof

#272
20210123018
2021-04-29

Methods of in vitro differentiation of midbrain dopamine (mDA) neurons

#273
20210102188
2021-04-08

Production and Therapeutic Uses of Epinul Cells and Differentiated Cells Derived Therefrom

#274
20210102164
2021-04-08

MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

#275
20210100847
2021-04-08

STEM CELLS FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY

#276
20210093676
2021-04-01

SOMATIC STEM CELLS FOR TREATING BONE DEFECTS

#277
20210087585
2021-03-25

TRANSDUCTION BUFFER

#278
20210087537
2021-03-25

ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF

#279
20210085725
2021-03-25

MESENCHYMAL-LIKE STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS, METHODS AND USES THEREOF

#280
20210077538
2021-03-18

Methods and compositions for treatment of penile defects

#281
20210062151
2021-03-04

Methods and compositions for inducing hematopoietic cell differentiation

#282
20210060148
2021-03-04

Method of inhibiting lung or breast cancer growth with engineered embryonic stem-cell derived exosomes compositions

#283
20210060101
2021-03-04

TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER

#284
20210054344
2021-02-25

CPC EXOSOMES MIRNA373 COMBINATION THERAPIES

#285
20210038764
2021-02-11

Protein biomaterials and biocoacervates and methods of making and using thereof

#286
20210033628
2021-02-04

DIAGNOSTIC AND DRUG SCREENING FOR MOLECULAR SIGNATURES OF EARLY ONSET SPORADIC PARKINSON'S DISEASE

#287
20210024891
2021-01-28

Methods and compositions for inducing hematopoietic cell differentiation

#288
20210023039
2021-01-28

PKC PATHWAY IN PARKINSON'S DISEASE

#289
20210017489
2021-01-21

Methods for selective inhibition of pluripotent stem cells

#290
20210015934
2021-01-21

Method of Treating Parkinson's Disease

#291
20210015859
2021-01-21

IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS

#292
20210009998
2021-01-14

Materials and methods for treatment of hemoglobinopathies

#293
20210008118
2021-01-14

METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS

#294
20200405774
2020-12-31

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

#295
20200399612
2020-12-24

Light mounting systems and methods

#296
20200390825
2020-12-17

PLURIPOTENT STEM CELL-DIRECTED MODEL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE FOR DISEASE MECHANISM AND DRUG DISCOVERY

#297
20200390821
2020-12-17

MODULATION OF SPLENOCYTES IN CELL THERAPY

#298
20200376169
2020-12-03

Compositions for Regenerating Defective or Absent Myocardium

#299
20200368394
2020-11-26

COMPOSITIONS AND METHODS FOR RESTORING OR PREVENTING LOSS OF VISION CAUSED BY DISEASE OR TRAUMATIC INJURY

#300
20200368291
2020-11-26

Cell population including adhesive stem cells, production method therefor and pharmaceutical composition